In a pre-budget submission, AusBiotech and MTPConnect have called for new investment in strategic initiatives to boost Australia’s life sciences sector, which is central to the nation’s productivity, health security and the health and wellbeing of all Australians.
In a pre-budget submission, AusBiotech and Medicines Australia called for the establishment of a Life Sciences Council, to drive the development of a new unified, whole-of-government, National Life Sciences Strategy.
AusBiotech and MTPConnect delivered Australia’s first National Biotech and Medtech Development and Commercialisation Summit in Canberra. This document contains the summit outcomes and following communique.
AusBiotech and MTPConnect released a Discussion Paper ahead of the National Biotech and Medtech Development and Commercialisation Summit, held on 19 November 2024 in Canberra.
The Cell and Gene Catalyst a joint-venture with AusBiotech and Medicines Australia are calling for collaboration with the cell and gene ecosystem for national coordination, accelerating the industry, and improving access to advanced therapies.
AusBiotech invites sector-wide feedback after releasing its draft Biotechnology Blueprint: A Decadal Strategy for the Australian Biotechnology Industry – a plan by the industry for the industry.